Qualitative research on fluoxetine and oxytocin in India

Patricia Jeffery, Stefan Ecks, Soumita Basu, Samita Bhattarai, Nitu Singh, Petra Brhilikova, Allyson Pollock, Madhusudan Sharma Subedi, Abhijit Das Gupta, Ian Harper, Roger Jeffery

Research output: Working paper


The first paper for this workshop addresses some aspects of the formal distribution system of pharmaceuticals in South Asia and indicates some ways in which the ground situation departs from the requirements of the formal regulations. This paper addresses similar issues, but from a rather different angle. The consumption of pharmaceuticals in the global South has been increasing, but there are varying interpretations of the reasons behind this. One perspective, for instance, suggests that the social and economic changes being wrought by processes of globalisation have generated ailments for which people seek relief and that is reflected in increasing demands for pharmaceuticals: here, pharmaceutical companies are simply meeting those demands. A rather different reading suggests that drug companies have been actively and successfully creating demands for their products by extending the psychiatric disease classifications used by doctors and potential patients/consumers and actively marketing the antidotes that deal with these new found ailments.
Original languageEnglish
PublisherUniversity of Edinburgh
Number of pages23
Publication statusPublished - 3 Jul 2007


Dive into the research topics of 'Qualitative research on fluoxetine and oxytocin in India'. Together they form a unique fingerprint.

Cite this